CVRx, Inc. (CVRX)


+0.36 (+4.01%)
Symbol CVRX
Price $9.33
Beta 0.000
Volume Avg. 0.05M
Market Cap 191.976M
Shares () -
52 Week Range 4.6-19.49
1y Target Est -
DCF Unlevered CVRX DCF ->
DCF Levered CVRX LDCF ->
ROE -26.70% Sell
ROA -28.18% Sell
Operating Margin -
Debt / Equity 5.42% Neutral
P/E 0.15 Neutral
P/B 1.50 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest CVRX news

Medical Devices
NASDAQ Global Select

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.